Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 1 Issue 11, November 2017

The US Food and Drug Administration requires direct-to-consumer advertisements of pharmaceutical drugs to mention not only severe side-effects, but also the most frequent, which can be minor. A series of experiments with more than 3,000 participants show that this practice dilutes consumers’ judgements of the overall severity of side effects.

See Sivanathan and Kakkar 1, 797–802 (2017)

Cover Design: Samantha Whitham.

Editorial

  • Advertisement

Top of page ⤴

Comment & Opinion

  • Moral outrage is an ancient emotion that is now widespread on digital media and online social networks. How might these new technologies change the expression of moral outrage and its social consequences?

    • M. J. Crockett
    Comment
  • Introduction of genetic evidence of a predisposition to violent or impulsive behaviour is on the rise in criminal trials. However, a panoply of data suggests that such evidence is ineffective at reducing judgements of culpability and punishment, and therefore its use in the legal process is likely to diminish.

    • Nicholas Scurich
    • Paul S. Appelbaum
    Comment
  • Advances in technology and the advent of social media have led to the emergence of a new phenomenon — cyberbullying. Although there are some similarities, approaches to tackling traditional bullying are largely ineffective in combating cyberbullying, which has been linked to adverse mental health and, in extreme cases, suicide.

    • Jean-Baptiste Pingault
    • Tabea Schoeler

    Collection:

    Comment
Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • In the United States, direct-to-consumer advertisements for medications must disclose each specific side-effect risk. A new study demonstrates a counterintuitive dilution effect: people perceive drug descriptions that include both serious and trivial side effects as less risky than descriptions that only list serious side effects.

    • Brian J. Zikmund-Fisher
    News & Views
Top of page ⤴

Reviews

  • Consistent failure over the past few decades to reduce the high prevalence of stress-related disorders has motivated a search for alternative research strategies. Resilience refers to the phenomenon of many people maintaining mental health despite exposure to psychological or physical adversity. Instead of aiming to understand the pathophysiology of stress-related disorders, resilience research focuses on protective mechanisms that shield people against the development of such disorders and tries to exploit its insights to improve treatment and, in particular, disease prevention. To fully harness the potential of resilience research, a critical appraisal of the current state of the art — in terms of basic concepts and key methods — is needed. We highlight challenges to resilience research and make concrete conceptual and methodological proposals to improve resilience research. Most importantly, we propose to focus research on the dynamic processes of successful adaptation to stressors in prospective longitudinal studies.

    • Raffael Kalisch
    • Dewleen G. Baker
    • Birgit Kleim
    Perspective
Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links